Categories Earnings, Health Care
Earnings Summary: Highlights of Centene Corp’s Q4 2023 financial results
Healthcare service provider Centene Corporation (NYSE: CNC) on Tuesday announced fourth-quarter 2023 results, reporting an increase in revenues and a fall in adjusted earnings.
- Fourth-quarter revenue increased to $39.46 billion from $35.56 billion in the prior year quarter
- Premium and Service revenues moved up 5% to $35.3 billion in Q4 from $33.6 billion in the comparable period of 2022
- Net income was $45 million or $0.08 per share in Q4, compared to a loss of $213 million or $0.38 per share last year
- Adjusted earnings declined to $0.45 per share in the fourth quarter from $0.86 per share in the same period last year
- The health benefits ratio was 89.5%, representing an increase from 88.7% in the year-ago period
- The company generated cash flow from operations of $217 million for the December quarter
- As of December 31, 2023, Centene had cash, investments, and restricted deposits of $37.3 billion
- During the quarter, the Company repurchased 397 thousand shares for $27 million
- The management raised its 2024 Premium & Service revenue guidance by $2.5 billion to $134.5-$137.5 billion
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Citigroup set to report Q4 2025 earnings. Here’s what to expect
Citigroup Inc. (NYSE: C) has undergone a sweeping transformation in recent years, emerging as a more streamlined and profitable financial institution. The bank's performance in recent quarters has underscored the
Home Depot (HD), Lowe’s (LOW): Home improvement pressures not expected to abate soon
Home improvement retailers Home Depot (NYSE: HD) and Lowe’s Companies, Inc. (NYSE: LOW) have been facing a challenging operating environment for a while now. The companies have been battling macroeconomic
Earnings Summary: AngioDynamics (ANGO) Q2 FY26 sales increase 8.8%
Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Tuesday reported an increase in net sales for the second quarter of fiscal 2026. In Q2, net sales increased 8.8% year-over-year to